Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Classificação em ações #25702
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Preço da ação
$2.09
Última sincronização: 2022-03-21
Valor de mercado
$47.04M
Variação (1 dia)
-0.48%
Variação (1 ano)
0.00%
País
US
Negociar Recro Pharma, Inc. (REPH)

Categoria

Histórico de rendimento de dividendos para Recro Pharma, Inc. (REPH)
O rendimento de dividendos (TTM) da Recro Pharma, Inc. (símbolo da ação: REPH) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Recro Pharma, Inc. (REPH) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes